Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities

University of Wisconsin School of Medicine and Public Health, Department of Medicine, Rheumatology Division, Madison, WI, USA; Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, Georgia, USA; Centers for Disease Control and Prevention, Division of Population Health; Emory University Rollins School of Public Health, Department of Epidemiology. No conflict of interest. The Georgians Organized Against Lupus (GOAL) Cohort was supported by 3U58DP001487-05W2 and U01DP05119 (Centers for Disease Control and Prevention). Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This study was presented at Plenary Session-I at the Annual American College of Rheumatology Meeting in Atlanta, November 2019. Address correspondence to Shivani Garg, MD MS, Assistant Professor, Dept. of Medicine, Rheumatology Division, University of Wisconsin School of Medicine & Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705. sgarg@medicine.wisc.edu

University of Wisconsin School of Medicine and Public Health, Department of Medicine, Rheumatology Division, Madison, WI, USA; Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, Georgia, USA; Centers for Disease Control and Prevention, Division of Population Health; Emory University Rollins School of Public Health, Department of Epidemiology. No conflict of interest. The Georgians Organized Against Lupus (GOAL) Cohort was supported by 3U58DP001487-05W2 and U01DP05119 (Centers for Disease Control and Prevention). Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This study was presented at Plenary Session-I at the Annual American College of Rheumatology Meeting in Atlanta, November 2019. Address correspondence to Shivani Garg, MD MS, Assistant Professor, Dept. of Medicine, Rheumatology Division, University of Wisconsin School of Medicine & Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705. sgarg@medicine.wisc.edu

University of Wisconsin School of Medicine and Public Health, Department of Medicine, Rheumatology Division, Madison, WI, USA; Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, Georgia, USA; Centers for Disease Control and Prevention, Division of Population Health; Emory University Rollins School of Public Health, Department of Epidemiology. No conflict of interest. The Georgians Organized Against Lupus (GOAL) Cohort was supported by 3U58DP001487-05W2 and U01DP05119 (Centers for Disease Control and Prevention). Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This study was presented at Plenary Session-I at the Annual American College of Rheumatology Meeting in Atlanta, November 2019. Address correspondence to Shivani Garg, MD MS, Assistant Professor, Dept. of Medicine, Rheumatology Division, University of Wisconsin School of Medicine & Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705. sgarg@medicine.wisc.edu

University of Wisconsin School of Medicine and Public Health, Department of Medicine, Rheumatology Division, Madison, WI, USA; Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, Georgia, USA; Centers for Disease Control and Prevention, Division of Population Health; Emory University Rollins School of Public Health, Department of Epidemiology. No conflict of interest. The Georgians Organized Against Lupus (GOAL) Cohort was supported by 3U58DP001487-05W2 and U01DP05119 (Centers for Disease Control and Prevention). Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This study was presented at Plenary Session-I at the Annual American College of Rheumatology Meeting in Atlanta, November 2019. Address correspondence to Shivani Garg, MD MS, Assistant Professor, Dept. of Medicine, Rheumatology Division, University of Wisconsin School of Medicine & Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705. sgarg@medicine.wisc.edu

University of Wisconsin School of Medicine and Public Health, Department of Medicine, Rheumatology Division, Madison, WI, USA; Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, Georgia, USA; Centers for Disease Control and Prevention, Division of Population Health; Emory University Rollins School of Public Health, Department of Epidemiology. No conflict of interest. The Georgians Organized Against Lupus (GOAL) Cohort was supported by 3U58DP001487-05W2 and U01DP05119 (Centers for Disease Control and Prevention). Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This study was presented at Plenary Session-I at the Annual American College of Rheumatology Meeting in Atlanta, November 2019. Address correspondence to Shivani Garg, MD MS, Assistant Professor, Dept. of Medicine, Rheumatology Division, University of Wisconsin School of Medicine & Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705. sgarg@medicine.wisc.edu

University of Wisconsin School of Medicine and Public Health, Department of Medicine, Rheumatology Division, Madison, WI, USA; Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, Georgia, USA; Centers for Disease Control and Prevention, Division of Population Health; Emory University Rollins School of Public Health, Department of Epidemiology. No conflict of interest. The Georgians Organized Against Lupus (GOAL) Cohort was supported by 3U58DP001487-05W2 and U01DP05119 (Centers for Disease Control and Prevention). Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This study was presented at Plenary Session-I at the Annual American College of Rheumatology Meeting in Atlanta, November 2019. Address correspondence to Shivani Garg, MD MS, Assistant Professor, Dept. of Medicine, Rheumatology Division, University of Wisconsin School of Medicine & Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705. sgarg@medicine.wisc.edu